121 related articles for article (PubMed ID: 37352081)
21. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
22. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
[TBL] [Abstract][Full Text] [Related]
23. Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.
Ning Y; Hanna DL; Zhang W; Mendez A; Yang D; El-Khoueiry R; Matsusaka S; Sunakawa Y; Stremitzer S; Parekh A; Okazaki S; Berger MD; Barzi A; Lenz HJ
Mol Cancer Ther; 2015 Oct; 14(10):2401-8. PubMed ID: 26227487
[TBL] [Abstract][Full Text] [Related]
24. Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.
Wu YK; Huang CY; Yang MC; Lan CC; Lee CH; Chan EC; Chen KT
Med Oncol; 2014 Aug; 31(8):79. PubMed ID: 24961465
[TBL] [Abstract][Full Text] [Related]
25. Expression of Survivin in pancreatic cancer and its correlation to expression of Bcl-2.
Qiao JG; Zhang YQ; Yin YC; Tan Z
World J Gastroenterol; 2004 Sep; 10(18):2759-61. PubMed ID: 15309737
[TBL] [Abstract][Full Text] [Related]
26. Importance of serum levels of angiopoietin-2 and survivin biomarkers in non-small cell lung cancer.
Fawzy A; Gaafar R; Kasem F; Ali SS; Elshafei M; Eldeib M
J Egypt Natl Canc Inst; 2012 Mar; 24(1):41-5. PubMed ID: 23587231
[TBL] [Abstract][Full Text] [Related]
27. Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease.
Grabowski P; Griss S; Arnold CN; Hörsch D; Göke R; Arnold R; Heine B; Stein H; Zeitz M; Scherübl H
Neuroendocrinology; 2005; 81(1):1-9. PubMed ID: 15809513
[TBL] [Abstract][Full Text] [Related]
28. Survivin mRNA Level in Blood Predict the Efficacy of Neoadjuvant Chemotherapy in Patients with Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hu YM; Li J; Yu LC; Shi SB; Du YJ; Wu JN; Shi WL
Pathol Oncol Res; 2015 Apr; 21(2):257-65. PubMed ID: 24980156
[TBL] [Abstract][Full Text] [Related]
29. The value of serum survivin level in early diagnosis of cancer.
Gunaldi M; Isiksacan N; Kocoglu H; Okuturlar Y; Gunaldi O; Topcu TO; Karabulut M
J Cancer Res Ther; 2018; 14(3):570-573. PubMed ID: 29893319
[TBL] [Abstract][Full Text] [Related]
30. Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study.
Nigam J; Chandra A; Kazmi HR; Singh A; Gupta V; Parmar D; Srivastava MK
Med Oncol; 2014 Sep; 31(9):167. PubMed ID: 25129311
[TBL] [Abstract][Full Text] [Related]
31. Early diagnostic value of survivin and its alternative splice variants in breast cancer.
Khan S; Bennit HF; Turay D; Perez M; Mirshahidi S; Yuan Y; Wall NR
BMC Cancer; 2014 Mar; 14():176. PubMed ID: 24620748
[TBL] [Abstract][Full Text] [Related]
32. Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer.
Wang J; Zhang X; Wei P; Zhang J; Niu Y; Kang N; Zhang Y; Zhang W; Xing N
World J Urol; 2014 Dec; 32(6):1477-84. PubMed ID: 24595485
[TBL] [Abstract][Full Text] [Related]
33. Serum bcl-2 and survivin levels in melanoma.
Tas F; Duranyildiz D; Argon A; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2004 Dec; 14(6):543-6. PubMed ID: 15577328
[TBL] [Abstract][Full Text] [Related]
34. Expression of antiapoptotic proteins livin and survivin in pediatric AML patients, as prognostic markers.
Zareifar S; Ghorbani S; Monabbati A; Bordbar MR; Zekavat OR; Abdolkarimi B; Haghpanah S
Pediatr Hematol Oncol; 2018 May; 35(4):250-256. PubMed ID: 30588872
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
36. Survivin expression and its potential clinical significance in gastrointestinal stromal sarcoma.
Baykara M; Akkus M; Yildiz R; Gonul II; Dursun A; Coskun U; Benekli M; Sevinc A; Dane F; Buyukberber S
Int Immunopharmacol; 2011 Dec; 11(12):2227-31. PubMed ID: 22020290
[TBL] [Abstract][Full Text] [Related]
37. [The study of the expression and the prognostic value of Survivin and Ki67 in pancreatic endocrine tumors].
Liu WW; Zheng Y; Xia ZL; Zhang SQ; Bao F; Lin ZM; Ji XH; Ying LL; Zhao LL; Xu MF; Cai Guo-Ping ; Chen GR
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 Jan; 31(1):72-5. PubMed ID: 26016245
[TBL] [Abstract][Full Text] [Related]
38. Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.
Meng H; Lu CD; Sun YL; Dai DJ; Lee SW; Tanigawa N
World J Gastroenterol; 2004 Nov; 10(22):3245-50. PubMed ID: 15484293
[TBL] [Abstract][Full Text] [Related]
39. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
[TBL] [Abstract][Full Text] [Related]
40. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
